Figure 3.
Interferon γ (IFN-γ) ELISPOT responses (spot forming units (SFU)/106 peripheral blood mononuclear cells (PBMC), median marked) to p57–73 QE65 (25 μg/ml) (A), tissue transglutaminase (tTG) deamidated gliadin (100 μg/ml) (B), and purified protein derivative of Mycobacterium bovis (PPD 5 μg/ml) (C) in patients with a new diagnosis of coeliac disease before adopting a gluten free diet (GFD) (“None”) (n = 11), and immediately before (Day 0) and on day 6 after a three day gluten challenge performed after following a strict GFD for one (n = 4), two (n = 5), or eight (n = 7) weeks.